Wilms Joris
Insider CIK 1753231 · YMAB Sr. VP and COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 42,900 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 35,700 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 32,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 35,700 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 32,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer | 2025-09-16 | 2025-09-18 | 39,301 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | U Tender | 2025-09-16 | 2025-09-18 | 12,799 | $8.60 | $110.1K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2025-01-17 | 2025-01-22 | 42,900 | — | $0 | 42,900 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2025-01-17 | 2025-01-22 | 21,500 | — | $0 | 52,100 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-08-26 | 2024-08-27 | 5,000 | $14.69 | $73.5K | 30,600 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-22 | 35,700 | — | $0 | 35,700 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2024-01-18 | 2024-01-22 | 17,800 | — | $0 | 35,600 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-01-26 | 2023-01-30 | 32,000 | — | $0 | 32,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-01-17 | 2023-01-19 | 35,700 | — | $0 | 35,700 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2023-01-17 | 2023-01-19 | 17,800 | — | $0 | 17,800 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2022-04-26 | 2022-04-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2021-12-14 | 2021-12-16 | 32,000 | — | $0 | 32,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-12-15 | 2020-12-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2019-12-10 | 2019-12-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2018-12-11 | 2018-12-13 | 20,000 | — | $0 | 20,000 | SEC↗ |